Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden
· Delayed Price · Currency is SEK 108.20
+0.20 (0.19%)
At close: Dec 5, 2025
Devyser Diagnostics AB Revenue
Devyser Diagnostics AB had revenue of 56.40M SEK in the quarter ending September 30, 2025, with 15.81% growth. This brings the company's revenue in the last twelve months to 242.70M, up 22.51% year-over-year. In the year 2024, Devyser Diagnostics AB had annual revenue of 216.90M with 28.12% growth.
Revenue (ttm)
242.70M
Revenue Growth
+22.51%
P/S Ratio
7.42
Revenue / Employee
2.25M
Employees
121
Market Cap
1.80B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 27.85B |
| Getinge AB | 35.85B |
| Sectra AB | 3.37B |
| Camurus AB | 2.35B |
| Medicover AB | 25.67B |
| Asker Healthcare Group AB | 16.41B |
| BioArctic AB | 1.92B |
| AddLife AB | 10.53B |